Literature DB >> 3198653

Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.

Z R Gan1, R J Gould, J W Jacobs, P A Friedman, M A Polokoff.   

Abstract

A 49-residue protein, echistatin, which inhibits platelet aggregation, was purified from the venom of the saw-scaled viper Echis carinatus. The purification procedure included gel filtration on Sephadex G-50, cation-exchange chromatography on Mono S, and C18 reverse-phase high pressure liquid chromatography. The purified protein was homogeneous as judged by polyacrylamide gel electrophoresis, isoelectric focusing, reverse-phase high pressure liquid chromatography, and NH2-terminal sequence analysis. Echistatin is a single-chain polypeptide with a molecular weight of 5400 and a native isoelectric point of 8.3. The most abundant amino acid, cysteine, accounts for 8 of the 49 residues in the protein. A 10-residue segment of echistatin shows 90% identity to a portion of the sequence of trigramin, a platelet aggregation inhibitor from the green tree viper Trimereserus gramineus (Huang, T.-F., Holt, J. C., Lukasiewicz, H., and Niewiarowski, S. (1987) J. Biol. Chem. 262, 16157-16163). Echistatin contains the sequence arginine-glycine-aspartic acid, which is common to proteins which bind to the glycoprotein IIb/IIIa complex. It also contains the sequence proline-arginine-asparagine-proline, which is found in the A alpha chain of human fibrinogen at position 267-270. The purified protein inhibits fibrinogen-dependent platelet aggregation initiated by ADP with an IC50 of 3 x 10(-8) M and also prevents aggregation initiated by thrombin, epinephrine, collagen, or platelet-activating factor. Reduction of echistatin abolished its inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198653

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Platelet aggregation is inhibited by phycolectins.

Authors:  K Matsubara; H Sumi; K Hori
Journal:  Experientia       Date:  1996-06-15

Review 2.  The current role of platelet-active drugs in ischaemic heart disease.

Authors:  D M Kerins; G A FitzGerald
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  An αIIbβ3- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis.

Authors:  Jian Jing; Yanna Sun
Journal:  J Biol Chem       Date:  2019-02-25       Impact factor: 5.157

4.  Integrins contribute to initial morphological development and process outgrowth in rat adult hippocampal progenitor cells.

Authors:  Matthew M Harper; Eun-Ah Ye; Christopher C Blong; Mark L Jacobson; Donald S Sakaguchi
Journal:  J Mol Neurosci       Date:  2009-06-05       Impact factor: 3.444

5.  Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP.

Authors:  J A Williams; B Ashby; J L Daniel
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

6.  Differential adhesion of metastatic RAW117 large-cell lymphoma cells under static or hydrodynamic conditions: role of integrin alpha(v) beta3.

Authors:  Z Yun; T W Smith; D G Menter; L V McIntire; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

7.  Integrin alpha(v)beta(3)-Targeted Cancer Therapy.

Authors:  Zhaofei Liu; Fan Wang; Xiaoyuan Chen
Journal:  Drug Dev Res       Date:  2008       Impact factor: 4.360

8.  Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

Authors:  B H Chao; J A Jakubowski; B Savage; E P Chow; U M Marzec; L A Harker; J M Maraganore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Integrin-directed modulation of macrophage responses to biomaterials.

Authors:  Toral D Zaveri; Jamal S Lewis; Natalia V Dolgova; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Biomaterials       Date:  2014-01-24       Impact factor: 12.479

10.  Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs.

Authors:  V M Garsky; P K Lumma; R M Freidinger; S M Pitzenberger; W C Randall; D F Veber; R J Gould; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.